Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  KHRNF | KHRWF | V.KHRN.WT.H

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

TSXV:KHRN.H - Post Discussion

Khiron Life Sciences Corp > Cash vs. Market Cap
View:
Post by haunsolo on Feb 20, 2020 3:26pm

Cash vs. Market Cap

So we don't know the current cash balance but it should be about $40 million CDN.

Market cap is currently $75 million CDN, so the company minus cash is valued at $35 million CDN.

Don't know about you all but that seems a little on the cheap side to me.

Lots of regulatory hurdles here, no near term cash flow until probably 2022, muted Kuida sales.

So we'll see.  I'm a buyer here.
Comment by JustAnotherLong on Feb 21, 2020 4:52pm
I worked out it got to 85% down from the absolute 12 month high. Even if it only retraces to 75% down that's $1.20 per share.
Comment by Chal112 on Feb 21, 2020 7:57pm
dont overly discount the value of Kuida.  Look out for surprising sales number in April for the brand.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities